K Yan, Y Gao, SL Heller - Clinical Breast Cancer, 2023 - Elsevier
Introduction Women with neurofibromatosis type 1 (NF1) have up to a 5-fold increased risk for breast cancer before age 50 and a 3.5-fold increased risk of breast cancer overall. The …
K Paalimäki-Paakki, M Virtanen, A Henner… - Radiography, 2023 - Elsevier
Introduction This study investigated whether a 360° virtual counselling environment (360° VCE) was more effective at decreasing patients' anxiety than routine standard of care …
C Plunkett, M Pilkington - Journal of Health Psychology, 2024 - journals.sagepub.com
Neurofibromatosis type 1 (NF1) predisposes individuals to benign and malignant tumours. Young women with NF1 (< 50 years) have an up to five-fold increased risk of breast cancer …
C Plunkett, M Pilkington - Journal of Health Psychology, 2024 - e-space.mmu.ac.uk
Neurofibromatosis type 1 (NF1) predisposes individuals to benign and malignant tumours. Young women with NF1 (< 50 years) have an up to five-fold increased risk of breast cancer …
Tiivistelmä Ahdistus sepelvaltimoiden tietokonetomografiatutkimuksessa (TT) voi heikentää potilasturvallisuutta, potilaan kuvantamiskokemuksen laatua, kuvanlaatua sekä lisätä …
M Wilding, J Fleming, K Moore, A Crook, R Reddy… - Familial Cancer, 2023 - Springer
Young women with Neurofibromatosis type 1 (NF1) have a high risk of developing breast cancer and poorer survival following breast cancer diagnosis. International guidelines …
Определение рисков развития онкологических заболеваний (ОЗ) позволило выстроить череду диагностических тестов для улучшения выявляемости и снижения смертности …
MA Zolotykh, AI Bilyalov… - Journal of Modern …, 2023 - modernonco.orscience.ru
Determination of cancer risk factors allow us to develop diagnostics tests that improved identification and reduced the rate of mortality of most frequent cancer diseases including …
Abstract Neurofibromatosis type 1 (NF-1) is an inherited neoplastic syndrome. Adults affected by NF-1 in Poland are mostly unaware of the disease-related risk of cancer. During …